-
1
-
-
0031616280
-
Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma
-
Horowitz B., Lazo A., Grossberg H., Page G., Lippin A., Swan G. Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma. Vox Sang 1998, 74(Suppl. 1):203-206.
-
(1998)
Vox Sang
, vol.74
, Issue.SUPPL. 1
, pp. 203-206
-
-
Horowitz, B.1
Lazo, A.2
Grossberg, H.3
Page, G.4
Lippin, A.5
Swan, G.6
-
2
-
-
0033792014
-
Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma
-
Koenigbauer U.F., Eastlund T., Day J.W. Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma. Transfusion 2000, 40:1203-1206.
-
(2000)
Transfusion
, vol.40
, pp. 1203-1206
-
-
Koenigbauer, U.F.1
Eastlund, T.2
Day, J.W.3
-
3
-
-
77955653363
-
-
Plasma humain (mélange de) traité pour viro-inactivation. Monographie no 1646. 1re éd. Pharmacopée européenne; [supplément 5.6]
-
Plasma humain (mélange de) traité pour viro-inactivation. Monographie no 1646. 1re éd. Pharmacopée européenne; 2006 [supplément 5.6].
-
(2006)
-
-
-
4
-
-
77955654456
-
-
Arrêté du 29 avril 2003 fixant la liste et les caractéristiques des produits sanguins labiles. Publié au Journal officiel de la République française le 28 mai 2003
-
Arrêté du 29 avril 2003 fixant la liste et les caractéristiques des produits sanguins labiles. Publié au Journal officiel de la République française le 28 mai 2003.
-
-
-
-
5
-
-
77955663971
-
-
Arrêté du 19 juillet 2005 modifiant l'arrêté du 29 avril 2003 fixant la liste et les caractéristiques des produits sanguins labiles. Publié au Journal officiel de la Répub
-
Arrêté du 19 juillet 2005 modifiant l'arrêté du 29 avril 2003 fixant la liste et les caractéristiques des produits sanguins labiles. Publié au Journal officiel de la République française le 24 août 2005.
-
-
-
-
6
-
-
77955655041
-
-
Méthode biologique 2.6.21: « Techniques d'amplification des acides nucléiques ». 6e éd. Pharmacopée européenne
-
Méthode biologique 2.6.21: « Techniques d'amplification des acides nucléiques ». 6e éd. Pharmacopée européenne.
-
-
-
-
7
-
-
77955663766
-
-
OMCL guideline for validation of nucleic acid amplification techniques (NAT) for quantification of B19 virus DNA in plasma pools. OCABR of biological substances;
-
OMCL guideline for validation of nucleic acid amplification techniques (NAT) for quantification of B19 virus DNA in plasma pools. OCABR of biological substances; 2008.
-
(2008)
-
-
-
8
-
-
0024601843
-
Clinical manifestations of human parvovirus B19 in adults
-
Woolf A.D., Campion G.V., Chishick A., Wise S., Cohen B.J., Klouda P.T., et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989, 149:1153-1156.
-
(1989)
Arch Intern Med
, vol.149
, pp. 1153-1156
-
-
Woolf, A.D.1
Campion, G.V.2
Chishick, A.3
Wise, S.4
Cohen, B.J.5
Klouda, P.T.6
-
9
-
-
0031034996
-
Human parvovirus B19 and blood products
-
Prowse C., Ludlam C.A., Yap P.L. Human parvovirus B19 and blood products. Vox Sang 1997, 72:1-10.
-
(1997)
Vox Sang
, vol.72
, pp. 1-10
-
-
Prowse, C.1
Ludlam, C.A.2
Yap, P.L.3
-
10
-
-
0034054020
-
Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation
-
Aubin J.T., Defer C., Vidaud M., Maniez Montreuil M., Flan B. Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation. Vox Sang 2000, 78:7-12.
-
(2000)
Vox Sang
, vol.78
, pp. 7-12
-
-
Aubin, J.T.1
Defer, C.2
Vidaud, M.3
Maniez Montreuil, M.4
Flan, B.5
-
11
-
-
0027475786
-
Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction
-
McOmish F., Yap P.L., Jordan A., Hart H., Cohen B.J., Simmonds P. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 1993, 31:323-328.
-
(1993)
J Clin Microbiol
, vol.31
, pp. 323-328
-
-
McOmish, F.1
Yap, P.L.2
Jordan, A.3
Hart, H.4
Cohen, B.J.5
Simmonds, P.6
-
12
-
-
0028862809
-
Incidence of human parvovirus B19 DNA detection in blood donors
-
Yoto Y., Kudoh T., Haseyama K., Suzuki N., Oda T., Katoh T., et al. Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 1995, 91:1017-1018.
-
(1995)
Br J Haematol
, vol.91
, pp. 1017-1018
-
-
Yoto, Y.1
Kudoh, T.2
Haseyama, K.3
Suzuki, N.4
Oda, T.5
Katoh, T.6
-
13
-
-
34548772435
-
Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay
-
Kleinman S.H., Glynn S.A., Lee T.H., Tobler L., Montalvo L., Todd D., et al. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 2007, 47:1756-1764.
-
(2007)
Transfusion
, vol.47
, pp. 1756-1764
-
-
Kleinman, S.H.1
Glynn, S.A.2
Lee, T.H.3
Tobler, L.4
Montalvo, L.5
Todd, D.6
-
14
-
-
0038795400
-
Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins
-
Thomas I., Di Giambattista M., Gérard C., Mathys E., Hougardy V., Latour B., et al. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang 2003, 84:300-307.
-
(2003)
Vox Sang
, vol.84
, pp. 300-307
-
-
Thomas, I.1
Di Giambattista, M.2
Gérard, C.3
Mathys, E.4
Hougardy, V.5
Latour, B.6
-
15
-
-
7644242099
-
Identification and characterization of persistent human erythrovirus infection in blood donor samples
-
Candotti D., Etiz N., Parsyan A., Allain J.P. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol 2004, 78:12169-12178.
-
(2004)
J Virol
, vol.78
, pp. 12169-12178
-
-
Candotti, D.1
Etiz, N.2
Parsyan, A.3
Allain, J.P.4
-
16
-
-
0035524555
-
Parvovirus B 19 DNA in plasma pools and plasma derivates
-
Schmidt I., Blümel J., Seitz H., Willkommen, Löwer J. Parvovirus B 19 DNA in plasma pools and plasma derivates. Vox Sang 2001, 81:228-235.
-
(2001)
Vox Sang
, vol.81
, pp. 228-235
-
-
Schmidt, I.1
Blümel, J.2
Seitz, H.3
Willkommen4
Löwer, J.5
-
17
-
-
0029934211
-
Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture
-
Saldanha J., Minor P. Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture. Br J Haematol 1996, 93:714-719.
-
(1996)
Br J Haematol
, vol.93
, pp. 714-719
-
-
Saldanha, J.1
Minor, P.2
-
18
-
-
0033011616
-
Parvovirus B19 DNA contamination in coagulation factor VIII products
-
Eis-Hübinger A.M., Sasowski U., Brackmann H.H. Parvovirus B19 DNA contamination in coagulation factor VIII products. Thromb Haemost 1999, 81:476-477.
-
(1999)
Thromb Haemost
, vol.81
, pp. 476-477
-
-
Eis-Hübinger, A.M.1
Sasowski, U.2
Brackmann, H.H.3
-
19
-
-
0029002859
-
Albumin batches and B19 parvovirus DNA
-
Lefrère J.J., Mariotti M., De la Croix I, Lerable J, Thauvin M, Burnouf T Albumin batches and B19 parvovirus DNA. Transfusion 1995, 35:389-391.
-
(1995)
Transfusion
, vol.35
, pp. 389-391
-
-
Lefrère, J.J.1
Mariotti, M.2
De la Croix, I.3
Lerable, J.4
Thauvin, M.5
Burnouf, T.6
-
20
-
-
0037714988
-
Detection of parvovirus B19 DNA in solvent-detergent plasma
-
[author reply 168]
-
Just B., Lefèvre H. Detection of parvovirus B19 DNA in solvent-detergent plasma. Vox Sang 2002, 83:167. [author reply 168].
-
(2002)
Vox Sang
, vol.83
, pp. 167
-
-
Just, B.1
Lefèvre, H.2
-
21
-
-
77955653912
-
-
Données d'hémovigilance. Afssaps; [non publiées]
-
Données d'hémovigilance. Afssaps; 2008 [non publiées].
-
(2008)
-
-
-
22
-
-
77955657621
-
-
CPMP/BWP/BPWG/4080/00: EMEA workshop (13th September 2000) on viral safety of plasma-derived medicinal products with particular focus on non-enveloped viruses. London: EMEA;
-
CPMP/BWP/BPWG/4080/00: EMEA workshop (13th September 2000) on viral safety of plasma-derived medicinal products with particular focus on non-enveloped viruses. London: EMEA; 2001.
-
(2001)
-
-
-
23
-
-
0002674151
-
Establishment of the first World Health Organization international standard for human parvovirus B19 DNA nucleic acid amplification techniques
-
B19 Collaborative Study Group
-
Saldanha J., Lelie N., Yu M.W., Heath A. Establishment of the first World Health Organization international standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang 2002, 82:24-31. B19 Collaborative Study Group.
-
(2002)
Vox Sang
, vol.82
, pp. 24-31
-
-
Saldanha, J.1
Lelie, N.2
Yu, M.W.3
Heath, A.4
-
24
-
-
77955658801
-
Validation de l'extraction combinée de l'ARN du virus de l'hépatite C et de l'ADN du parvovirus B19 par l'automate Nuclisens EasyMag développé par BioMérieux
-
e Congrès national de la SFTS, Tours
-
Lapeyre M., Goujon N., Lièvre V., Mouillot L., Tissier M.H. Validation de l'extraction combinée de l'ARN du virus de l'hépatite C et de l'ADN du parvovirus B19 par l'automate Nuclisens EasyMag développé par BioMérieux. Transfus Clin Biol 2007, 14(2):240. [poster 045].
-
(2007)
Transfus Clin Biol
, vol.14
, Issue.2
, pp. 240
-
-
Lapeyre, M.1
Goujon, N.2
Lièvre, V.3
Mouillot, L.4
Tissier, M.H.5
-
25
-
-
0036720405
-
Genetic diversity within human erythroviruses: identification of three genotypes
-
Servant A., Laperche S., Lallemand F., Marinho V., De Saint Maur G., Meritet J.F., et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002, 76:9124-9134.
-
(2002)
J Virol
, vol.76
, pp. 9124-9134
-
-
Servant, A.1
Laperche, S.2
Lallemand, F.3
Marinho, V.4
De Saint Maur, G.5
Meritet, J.F.6
-
26
-
-
33646412583
-
Genetic variants of parvovirus B19 identified in the United Kingdom: implications for diagnosis testing
-
Cohen B.J., Gandhi J., Clewley J.P. Genetic variants of parvovirus B19 identified in the United Kingdom: implications for diagnosis testing. J Clin Virol 2006, 36:152-155.
-
(2006)
J Clin Virol
, vol.36
, pp. 152-155
-
-
Cohen, B.J.1
Gandhi, J.2
Clewley, J.P.3
|